Search For "priyanka sharma"
Updated : 10 months, 3 weeks ago IST
New Delhi [India], Aug 4 (ANI): In a first in India, the technical expert committee at the Union Health Ministry created Prescribed Minimum Essential Specifications for "Make in India ventilators" to be used in COVID-19 ICU, a senior health ministry official said on Tuesday.
Updated : 11 months ago IST
New Delhi [India], July 24 (ANI): The All India Institute of Medical Sciences (AIIMS) on Friday administered the first dose of country's first indigenous vaccine candidate `Covaxin' to a 30-year-old man as part of efforts to combat COVID-19.
Updated : 11 months, 1 week ago IST
New Delhi [India], July 18 (ANI): The All India Institute of Medical Sciences (AIIMS) Ethics Committee on Saturday gave its approval for conducting the human clinical trial of the indigenously developed COVID-19 vaccine candidate Covaxin.
New Delhi, [India], July 18 (ANI): The Union Health Ministry has directed the government of Bihar, Odisha, West Bengal and Assam to take necessary steps to suppress COVID-19 transmission as well as to keep case fatality rate below 1 per cent.
New Delhi [India], July 15 (ANI): Indian pharmaceutical giant Zydus Cadila has initiated the phase 1, 2 clinical trial to evaluate the safety and immunogenicity of coronavirus vaccine candidate by intradermal (injection) route in 1,048 subjects after the pharma company got approval from D
New Delhi [India], July 14 (ANI): The Union Health Ministry on Tuesday informed that the daily growth rate of newer coronavirus cases is declining each day. Till July 12, the Central government has recorded daily the growth rate for newer cases at 3.24 per cent.
Updated : 11 months, 2 weeks ago IST
New Delhi [India], July 11 (ANI): The Drug Controller General of India (DCGI) granted its permission to Itolizumab injection for the restricted emergency use on COVID-19 patients with moderate to severe Acute Respiratory Distress Syndrome (ARDS) due to virus.
Updated : 11 months, 3 weeks ago IST
New Delhi [India], July 3 (ANI): The Drug Controller General of India (DCGI) on Thursday granted permission to pharma giant Zydus Cadila to conduct phase I and phase II human clinical trials for COVID -19 vaccine, a top government official told ANI.
Updated : 1 year ago IST
New Delhi [India], June 22 (ANI): The National Centre for Disease Control (NCDC) is set to conduct a sero-surveillance study in all 11 districts of Delhi focusing on as many as 20,000 households on a random basis including individuals below 18 years of age. The survey is expected to start
New Delhi [India], June 13 (ANI): The Union Health Ministry issued a fresh clinical management protocol for COVID-19 patients on Saturday. As per the latest protocol, the health ministry has described the use of investigational therapies--Remdesivir, Convalescent plasma, Tocilizumab, and
Updated : 1 year, 1 month ago IST
New Delhi [India], May 22 (ANI): After some promising results on the efficacy of prophylactic use of Hydroxychloroquine (HCQ) against COVID-19 infection, the Central government has expanded the use of the medicine as prophylaxis to healthcare and other frontline workers deployed in non-CO
New Delhi [India], May 20 (ANI): An interim report prepared by the Telangana government has yielded promising results on the efficacy of prophylactic use of Hydroxychloroquine or HCQ, as it is popularly known, on preventing COVID-19 in frontline medical workers in the state.